Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2024 Dec;25(12):105294.
doi: 10.1016/j.jamda.2024.105294. Epub 2024 Oct 4.

Comparative Effectiveness and Safety of Direct Oral Anticoagulants vs Warfarin among Nursing Home Residents with Atrial Fibrillation: A Retrospective Cohort Study

Hemalkumar B Mehta  1 , Xuya Xiao  2 , Huijun An  2 , G Caleb Alexander  3
Affiliations
Comparative Study

Comparative Effectiveness and Safety of Direct Oral Anticoagulants vs Warfarin among Nursing Home Residents with Atrial Fibrillation: A Retrospective Cohort Study

Hemalkumar B Mehta et al. J Am Med Dir Assoc. 2024 Dec.

Abstract

Objective: Residents of nursing homes are usually excluded from clinical trials, including trials to assess treatments for common conditions such as nonvalvular atrial fibrillation (NVAF). We aimed to quantify the real-world comparative safety and effectiveness of direct-acting oral anticoagulants (DOACs) vs warfarin among nursing home residents with NVAF.

Design: Retrospective cohort study using 100% national Minimum Data Set and linked Medicare claims from January 2011 through December 2018.

Setting and participants: Long-term care nursing home residents aged ≥66 years enrolled in fee-for-service Medicare. We included individuals diagnosed with NVAF newly initiating oral anticoagulants.

Methods: We identified exposure to DOACs (apixaban, dabigatran, rivaroxaban, and edoxaban) vs warfarin. Outcomes were hospitalization for ischemic stroke/systemic embolism, major bleeding, pneumonia (negative control outcome), and all-cause death. We used inverse probability of treatment weighting competing risk regression models for clinical outcomes and Cox proportional hazards regression for all-cause death.

Results: Of 38,983 individuals newly initiating anticoagulants, 19,366 (49.7%) initiated DOACs and 19,617 (50.3%) initiated warfarin. In the inverse probability of treatment weighting analysis, compared with warfarin, there was no statistically significant association between DOAC use and ischemic stroke/systemic embolism [4.5 vs 4.7 events per 100 person-years; adjusted hazard ratio (aHR), 0.94; 95% CI, 0.84-1.05] or major bleeding (12.6 vs 12.4 events per 100 person-years; aHR, 1.03; 95% CI, 0.96-1.10). DOACs use was associated with a modest but statistically significant lower risk of all-cause death (48.1 vs 49.0 events per 100 person-years; IPTW analysis aHR, 0.95; 95% CI, 0.91-0.98).

Conclusions and implications: Among nursing home residents with NVAF, DOACs and warfarin were associated with a similar risk of ischemic stroke/systemic embolism and major bleeding. However, the use of DOACs was associated with a slightly reduced risk of all-cause mortality.

Keywords: Direct-acting oral anticoagulants; atrial fibrillation; comparative effectiveness; nursing home; warfarin.

PubMed Disclaimer

Conflict of interest statement

Disclosure Dr Alexander is past Chair of FDA's Peripheral and Central Nervous System Advisory Committee and a co-founding principal and equity holder in Stage Analytics. These arrangements have been reviewed and approved by Johns Hopkins University in accordance with its conflict of interest policies. The other authors declare no conflicts of interest.

References

    1. Reardon G, Nelson WW, Patel AA, Philpot T, Neidecker M. Prevalence of atrial fibrillation in US nursing homes: results from the National Nursing Home Survey, 1985-2004. J Am Med Dir Assoc. 2012;13(6):529–534. doi:10.1016/j.jamda.2012.03.007 - DOI - PubMed
    1. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114(2):119–125. doi:10.1161/CIRCULATIONAHA.105.595140 - DOI - PubMed
    1. Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112(8):1142–1147. doi:10.1016/j.amjcard.2013.05.063 - DOI - PubMed
    1. Lim GB. Milestone 2: Warfarin: from rat poison to clinical use [published online ahead of print, 2017 Dec 14]. Nat Rev Cardiol. 2017;10.1038/nrcardio.2017.172. doi:10.1038/nrcardio.2017.172 - DOI - PubMed
    1. Alcusky M, McManus DD, Hume AL, Fisher M, Tjia J, Lapane KL. Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016. J Am Heart Assoc. 2019;8(9):e012023. doi:10.1161/JAHA.119.012023 - DOI - PMC - PubMed

Publication types

MeSH terms